North Carolina S450 updates the Controlled Substances Act to classify new opiates, fentanyl derivatives, nitazene derivatives, and synthetic.

North Carolina S450, the Novel Opioid Control Act of 2025, amends the Controlled Substances Act to classify new opiates, fentanyl derivatives, nitazene derivatives, and synthetic cannabinoids as controlled substances. This includes compounds structurally derived from benzimidazole, fentanyl, and indazole, among others. The act also specifies that these substances are controlled regardless of their modification or substitution. This legislation aims to address the evolving landscape of opioid and synthetic drug threats by updating the state's controlled substances list.

North Carolina S450 updates the Controlled Substances Act to classify new opiates, fentanyl derivatives, nitazene derivatives, and synthetic.

North Carolina S450, the Novel Opioid Control Act of 2025, amends the Controlled Substances Act to classify new opiates, fentanyl derivatives, nitazene derivatives, and synthetic cannabinoids as controlled substances. This includes compounds structurally derived from benzimidazole, fentanyl, and indazole, among others. The act also specifies that these substances are controlled regardless of their modification or substitution. This legislation aims to address the evolving landscape of opioid and synthetic drug threats by updating the state's controlled substances list.